Fairhead C - Search Results

1

Safety and efficacy of long-acting cabotegravir/rilpivirine versus standard oral antiretroviral therapy: a systematic review and meta-analysis.

Manalu SBPS, Perez Navarro A, Fairhead C, Hill A. Manalu SBPS, et al. Among authors: fairhead c. J Antimicrob Chemother. 2025 Jan 8:dkae480. doi: 10.1093/jac/dkae480. Online ahead of print. J Antimicrob Chemother. 2025. PMID: 39776187

2

Clinical staff attitudes towards opt-out consent for blood-borne virus screening in emergency departments in England.

Blakey EG, Fairhead CEL, Rodger AJ, Burns FM, Ralph L, Chadwick DR. Blakey EG, et al. Among authors: fairhead cel. HIV Med. 2024 Nov 13. doi: 10.1111/hiv.13735. Online ahead of print. HIV Med. 2024. PMID: 39539081

3

Results from systematic review and meta-analysis of the efficacy and safety of two-drug versus three-drug ( Tenofovir/Lamivudine/Dolutegravir; TLD) regimens for HIV treatment.

Fairhead C, Levi J, Ramesh N, Hill A. Fairhead C, et al. Clin Infect Dis. 2024 Sep 30:ciae490. doi: 10.1093/cid/ciae490. Online ahead of print. Clin Infect Dis. 2024. PMID: 39344489 No abstract available.

4

Lenacapavir to prevent HIV infection: current prices versus estimated costs of production.

Hill A, Levi J, Fairhead C, Pilkington V, Wang J, Johnson M, Layne J, Roberts D, Fortunak J. Hill A, et al. Among authors: fairhead c. J Antimicrob Chemother. 2024 Nov 4;79(11):2906-2915. doi: 10.1093/jac/dkae305. J Antimicrob Chemother. 2024. PMID: 39225016

5

In vivo CRISPR-Cas9 expression in Candida glabrata, Candida bracarensis, and Candida nivariensis: A versatile tool to study chromosomal break repair.

Métivier K, Zhou-Li Y, Fairhead C. Métivier K, et al. Among authors: fairhead c. Yeast. 2024 Sep;41(9):560-567. doi: 10.1002/yea.3976. Epub 2024 Aug 9. Yeast. 2024. PMID: 39126214

6

Low CD4 counts predict excessive weight gains during first-line treatment for HIV.

Hill A, Tovar Sanchez T, Delaporte E, Sokhela S, Simmons B, Kouanfack C, Mccann K, Levi J, Fairhead C, Venter F. Hill A, et al. Among authors: fairhead c. J Antimicrob Chemother. 2024 Sep 3;79(9):2369-2378. doi: 10.1093/jac/dkae238. J Antimicrob Chemother. 2024. PMID: 39028639

7

Challenges for novel antiretroviral development in an era of widespread TLD availability.

Fairhead C, Levi J, Hill A. Fairhead C, et al. Clin Infect Dis. 2024 Jul 11:ciae361. doi: 10.1093/cid/ciae361. Online ahead of print. Clin Infect Dis. 2024. PMID: 38991021

8

Intersections between HIV and obesity in emerging economies.

Levi J, Fairhead C, Hill A. Levi J, et al. Among authors: fairhead c. Curr Opin HIV AIDS. 2024 Jan 1;19(1):35-44. doi: 10.1097/COH.0000000000000827. Epub 2023 Nov 3. Curr Opin HIV AIDS. 2024. PMID: 37922195 Review.

9

Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy.

Fox JM, Lee MJ, Fairhead CL, Ledwaba-Chapman LM, Nori AV, McQuillan O, Wang Y, Clarke A, Menon-Johansson A. Fox JM, et al. Among authors: fairhead cl. Sex Transm Infect. 2023 Aug 17;99(6):367-372. doi: 10.1136/sextrans-2022-055622. Sex Transm Infect. 2023. PMID: 36564186 Clinical Trial.

10

Patterns of Genomic Variation in the Opportunistic Pathogen Candida glabrata Suggest the Existence of Mating and a Secondary Association with Humans.

Carreté L, Ksiezopolska E, Pegueroles C, Gómez-Molero E, Saus E, Iraola-Guzmán S, Loska D, Bader O, Fairhead C, Gabaldón T. Carreté L, et al. Among authors: fairhead c. Curr Biol. 2022 Jul 25;32(14):3219. doi: 10.1016/j.cub.2022.06.082. Curr Biol. 2022. PMID: 35882189 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters